SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: David Howe who wrote (2082)3/23/1999 6:03:00 PM
From: rkrw  Respond to of 10280
 
Prozac is an equal mix of both isomers. So 50/50 chance you get R, 50/50 chance you get S. The FDA will not require generic mfg's to prove their fluoxetine batches are equivalent in mix to Prozac. Like any drug, they need only prove bioequivalence which they do in their own small clinical trials. In fact quite a few generic versions are already approved pending Prozacs patent expirations, including Barr Labs version.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News